Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer

MeSH terms

• Antineoplastic Agents / economics
• Antineoplastic Agents / therapeutic use*
• Biomarkers, Tumor / genetics*
• Breast Neoplasms / genetics
• Breast Neoplasms / mortality
• Breast Neoplasms / pathology
• Breast Neoplasms / therapy*
• Chemotherapy, Adjuvant / economics
• Cost Savings
• Cost-Benefit Analysis
• Drug Costs
• Female
• Gene Expression Profiling / economics*
• Gene Expression Profiling / methods
• Gene Expression Regulation, Neoplastic
• Health Care Costs*
• Humans
• Models, Economic
• Monte Carlo Method
• Neoplasm Staging
• Oligonucleotide Array Sequence Analysis / economics*
• Patient Selection*
• Pharmacogenetics / economics*
• Pharmacogenetics / methods
• Predictive Value of Tests
• Quality-Adjusted Life Years
• Receptors, Estrogen / analysis
• Reproducibility of Results
• Risk Assessment
• Time Factors
• Treatment Outcome